Market Access - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

For reimbursement of a medicinal product by the health insurance providers in Switzerland, the Swiss Federal Office of Public Health (BAG) requires proof of the efficacy, appropriateness and cost-effectiveness of the medicinal product for marketing approval. We provide our expertise for this purpose.

Strategic consultation

Benefit from our experience to quickly achieve reimbursement for your medicinal products:
• Definition of the adequate price strategy (foreign price comparison, therapeutic cross-comparison)
• Review and, if necessary, optimisation of the current pricing strategy
• Negotiations with the authorities (Swiss Federal Office of Public Health (BAG))

Operational support

We would be happy to support you in the areas of:
• Literature searches for the relevant decision criteria, including evaluation
• Documentation of the effectiveness, appropriateness and economic viability
• Drafting of applications for health insurance reimbursement
• Review of acceptance criteria every three years or after patent expiry

More About This Company